BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 36925927)

  • 21. Machine learning-based identification of cuproptosis-related markers and immune infiltration in severe community-acquired pneumonia.
    Chen S; Zhou Z; Wang Y; Chen S; Jiang J
    Clin Respir J; 2023 Jul; 17(7):618-628. PubMed ID: 37279744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pan-cancer analysis of cuproptosis regulation patterns and identification of mTOR-target responder in clear cell renal cell carcinoma.
    Long S; Wang Y; Chen Y; Fang T; Yao Y; Fu K
    Biol Direct; 2022 Oct; 17(1):28. PubMed ID: 36209249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Novel Cuproptosis-Related Prognostic Gene Signature and Validation of Differential Expression in Clear Cell Renal Cell Carcinoma.
    Bian Z; Fan R; Xie L
    Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Copper homeostasis and cuproptosis in tumor pathogenesis and therapeutic strategies.
    Bian C; Zheng Z; Su J; Chang S; Yu H; Bao J; Xin Y; Jiang X
    Front Pharmacol; 2023; 14():1271613. PubMed ID: 37767404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High expression of cuproptosis-related SLC31A1 gene in relation to unfavorable outcome and deregulated immune cell infiltration in breast cancer: an analysis based on public databases.
    Li L; Li L; Sun Q
    BMC Bioinformatics; 2022 Aug; 23(1):350. PubMed ID: 35996075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The mechanism of copper transporters in ovarian cancer cells and the prospect of cuproptosis.
    Guo J; Sun Y; Liu G
    J Inorg Biochem; 2023 Oct; 247():112324. PubMed ID: 37481825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel cuproptosis-related gene signature of prognosis and immune microenvironment in head and neck squamous cell carcinoma cancer.
    Jiang X; Ke J; Jia L; An X; Ma H; Li Z; Yuan W
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):203-218. PubMed ID: 36376617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel Cuproptosis-Related Gene Signature for Precise Identification of High-Risk Populations in Low-Grade Gliomas.
    Chen P; Han H; Wang X; Wang B; Wang Z
    Mediators Inflamm; 2023; 2023():6232620. PubMed ID: 36814682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cuproptosis regulatory genes greatly contribute to clinical assessments of hepatocellular carcinoma.
    Ke C; Dai S; Xu F; Yuan J; Fan S; Chen Y; Yang L; Li Y
    BMC Cancer; 2023 Jan; 23(1):25. PubMed ID: 36611155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulatory roles of copper metabolism and cuproptosis in human cancers.
    Wang Z; Jin D; Zhou S; Dong N; Ji Y; An P; Wang J; Luo Y; Luo J
    Front Oncol; 2023; 13():1123420. PubMed ID: 37035162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Copper homeostasis and cuproptosis in mitochondria.
    Tian Z; Jiang S; Zhou J; Zhang W
    Life Sci; 2023 Dec; 334():122223. PubMed ID: 38084674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel cuproptosis-related prognostic 2-lncRNAs signature in breast cancer.
    Xu QT; Wang ZW; Cai MY; Wei JF; Ding Q
    Front Pharmacol; 2022; 13():1115608. PubMed ID: 36699089
    [No Abstract]   [Full Text] [Related]  

  • 34. Comprehensive analysis of cuproptosis-related genes and tumor microenvironment infiltration characterization in breast cancer.
    Song S; Zhang M; Xie P; Wang S; Wang Y
    Front Immunol; 2022; 13():978909. PubMed ID: 36341328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Roles and mechanisms of copper homeostasis and cuproptosis in osteoarticular diseases.
    Han J; Luo J; Wang C; Kapilevich L; Zhang XA
    Biomed Pharmacother; 2024 May; 174():116570. PubMed ID: 38599063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of immune infiltration and cuproptosis-related subgroups in Crohn's disease.
    Yuan Y; Fu M; Li N; Ye M
    Front Immunol; 2022; 13():1074271. PubMed ID: 36466876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic analysis of cuproptosis subtypes and immunological features in severe influenza.
    Chen L; Hua J; He X
    Microb Pathog; 2023 Jul; 180():106162. PubMed ID: 37207785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive investigation into cuproptosis in the characterization of clinical features, molecular characteristics, and immune situations of clear cell renal cell carcinoma.
    Wang B; Song Q; Wei Y; Wu X; Han T; Bu H; Tang S; Qian J; Shao P
    Front Immunol; 2022; 13():948042. PubMed ID: 36275737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cuproptosis-Related MiR-21-5p/FDX1 Axis in Clear Cell Renal Cell Carcinoma and Its Potential Impact on Tumor Microenvironment.
    Xie M; Cheng B; Yu S; He Y; Cao Y; Zhou T; Han K; Dai R; Wang R
    Cells; 2022 Dec; 12(1):. PubMed ID: 36611966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The expression of cuproptosis-related genes in hepatocellular carcinoma and their relationships with prognosis.
    Zhao X; Chen J; Yin S; Shi J; Zheng M; He C; Meng H; Han Y; Han J; Guo J; Yuan Z; Wang Y
    Front Oncol; 2022; 12():992468. PubMed ID: 36313717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.